NYSE · Analyst Forecast

Pfizer, Inc. (PFE) Stock Forecast & Price Target

$28.96 NYSE: PFE Market Cap $165.07B

Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Pfizer, Inc. (PFE), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Pfizer, Inc., analysts forecast revenue falling from $61.94B in 2025 to $54.34B in 2030; the average estimate for 2030 earnings per share is $2.35; with published estimates ranging from $2.25 to $2.44; 22 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$28.96
Consensus targetThe average of the price targets analysts have published.$30.89
Median targetThe middle target, less affected by a single outlier.$30.00
Highest targetThe most optimistic published target.$40.00
Lowest targetThe most pessimistic published target.$26.00
Difference from priceHow far the consensus target sits from today’s price.+6.7%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$61.61B$61.94B$62.08B17
2026$61.50B$63.00B$63.73B18
2027$59.35B$60.60B$62.57B18
2028$51.81B$55.28B$58.21B22
2029$51.92B$53.64B$55.19B14
2030$52.60B$54.34B$55.91B11

Earnings per share forecast

YearLowAverageHighAnalysts
2025$3.04$3.12$3.2317
2026$2.91$3.03$3.2518
2027$2.73$2.94$3.1618
2028$1.60$2.48$2.7222
2029$2.19$2.28$2.3714
2030$2.25$2.35$2.4411

Pfizer, Inc. (PFE) forecast — frequently asked questions

What is the analyst price target for Pfizer, Inc.?

Analysts covering Pfizer, Inc. (PFE) have a consensus price target of $30.89, 6.7% above the current price of $28.96. Published targets range from $26.00 to $40.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Pfizer, Inc.'s earnings?

The average analyst estimate for Pfizer, Inc. (PFE) earnings per share in 2030 is 2.35, with individual estimates between 2.25 and 2.44.

How much revenue is Pfizer, Inc. expected to make?

Analysts forecast Pfizer, Inc. (PFE) revenue of $54.34B in 2030, based on 11 published estimates.

How many analysts cover PFE?

22 analysts contribute estimates for Pfizer, Inc. (PFE). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - General stocks

LLY forecastJNJ forecastABBV forecastMRK forecastNVS forecastAZN forecastAMGN forecastGILD forecastNVO forecastBMY forecastAll Drug Manufacturers - General stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.